1. Home
  2. ALEX vs NVCR Comparison

ALEX vs NVCR Comparison

Compare ALEX & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alexander & Baldwin Inc. REIT Holding Company

ALEX

Alexander & Baldwin Inc. REIT Holding Company

HOLD

Current Price

$20.78

Market Cap

1.5B

Sector

Real Estate

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$10.99

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALEX
NVCR
Founded
1870
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
ALEX
NVCR
Price
$20.78
$10.99
Analyst Decision
Hold
Buy
Analyst Count
3
6
Target Price
$21.00
$27.75
AVG Volume (30 Days)
671.0K
2.4M
Earning Date
02-27-2026
02-26-2026
Dividend Yield
6.74%
N/A
EPS Growth
65.09
N/A
EPS
1.01
N/A
Revenue
$226,062,000.00
$642,269,000.00
Revenue This Year
N/A
$10.64
Revenue Next Year
$2.12
$5.37
P/E Ratio
$20.53
N/A
Revenue Growth
N/A
11.17
52 Week Low
$15.07
$9.82
52 Week High
$21.03
$22.95

Technical Indicators

Market Signals
Indicator
ALEX
NVCR
Relative Strength Index (RSI) 66.97 42.29
Support Level $20.73 $9.82
Resistance Level $20.77 $14.97
Average True Range (ATR) 0.04 0.89
MACD -0.06 -0.07
Stochastic Oscillator 72.73 22.72

Price Performance

Historical Comparison
ALEX
NVCR

About ALEX Alexander & Baldwin Inc. REIT Holding Company

Alexander & Baldwin Inc is a Hawaii commercial real estate company. The group owns, operates, and manages million square feet of retail, industrial, and office space in Hawaii. It is a real estate investment trust (REIT) and the owner of grocery and drug-anchored retail centers in the state. It functions through two segments namely Commercial Real Estate and Land Operations. The Commercial Real Estate segment owns and manages retail, industrial spaces, and also urban ground leases in Hawaii, thereby accounting for a majority of the company's revenue. The Land Operations segment actively manages the company's land and real estate-related assets and makes optimum utilization of these assets. Geographically, the activities are carried out across the United States.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: